Tear film osmolarity measurements can diagnose dry eye disease

Article

Measuring tear film osmolarity is very effective in diagnosing dry eye disease.

Measuring tear film osmolarity is very effective in diagnosing dry eye disease, according to a paper published in Cornea.

The investigation led by Dr Christina Jacobi, Department of Ophthalmology, University of Erlangen-Nuremberg, Erlangen, Germany, involved 133 patients with moderate to severe keratoconjunctivitus sicca and 95 control participants. Each participant had tear samples taken directly from the inferior lateral tear meniscus. The TearLab osmometer was used to analyse tear film osmolarity.

The inclusion criteria was a Schirmer test with anaesthesia of less than 5 mm, a tear breakup time of less than 5 seconds and positive symptoms where the Ocular Surface Disease Index Score was over 83.

A tear film osmolarity of 320 mOsmol/L was found in the patients with moderate to severe keratoconjunctivitis. The control group presented with a tear film osmolarity of 301 mOsmol/L. Tear film osmolarity was significantly higher in patients with moderate to severe keratoconjunctivitus sicca compared to the control group. The study also confirmed that the official referent value in moderate to severe dry eye was approximately 316 mOsmol/L.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.